BrightSpring posts strong Q3 2026 results and lifts FY2026 revenue and EBITDA outlook
BrightSpring Health Services reported third‑quarter 2026 revenue of $4.213 billion, up 26.4% year‑over‑year, and net income from continuing operations of $101 million. Adjusted EBITDA rose 42% to $228 million and leverage improved to 1.79 x. The company raised its full‑year 2026 revenue forecast to $15.9 billion‑$16.125 billion and adjusted EBITDA guidance to $850 million‑$860 million.
Why it matters
The higher guidance signals stronger growth expectations for the year, which could support a higher valuation for BTSG investors (the company said the outlook excludes future acquisitions). The lower leverage gives the firm more flexibility for further acquisitions.
Key facts
- 1Q3 2026 net revenue was $4,213 million, a 26.4% increase versus $3,334 million in Q3 2025. stocktitan.net
- 2Net income from continuing operations was $101 million, compared with $38 million a year earlier. stocktitan.net
- 3Adjusted EBITDA for the quarter was $228 million, up 42.0% from $160 million in Q3 2025. stocktitan.net
- 4Leverage at September 30, 2026 was 1.79 x, down from 2.15 x on June 30, 2026. stocktitan.net
- 5Full‑year 2026 revenue guidance was raised to $15,900 million‑$16,125 million, implying 23.2%‑24.9% growth versus 2025. stocktitan.net
- 6Full‑year 2026 adjusted EBITDA guidance was raised to $850 million‑$860 million, implying 37.6%‑39.3% growth versus 2025. stocktitan.net
Summary written by AlphAI AI Desk from 14 of 14 sources. Not investment advice. Figures are as stated by the linked sources.